Multiple Myeloma
News
FDA scrutinizes cancer therapies granted accelerated approval
News
‘Phenomenal’ results with CAR T cells in R/R multiple myeloma
News
Caregiver burden of outpatient ASCT for multiple myeloma comparable with inpatient transplant
But only if caregivers are equipped for outpatient care.
Conference Coverage
Study found dual-targeted CAR T highly active against relapsed/refractory multiple myeloma
News
Extended virus shedding after COVID-19 in some patients with cancer
Some patients, including stem cell transplant and CAR T recipients, may require extended periods of isolation.
Conference Coverage
Five-minute SC injection of daratumumab in RRMM
“The appeal of subcutaneous daratumumab is the 5 minutes it needs for administering, cutting down considerable on ‘chair/clinic’ time.”
Conference Coverage
Durable responses with anti-BCMA CAR T-cell for multiple myeloma
Seventy-two percent of patients with relapsed/refractory multiple myeloma had ongoing responses at the time of data cutoff in the CARTITUDE-1...
Conference Coverage
COVID-19–related outcomes poor for patients with hematologic disease in ASH registry
News
Circulating miRNA could be a potential biomarker for early diagnosis of MM
A meta-analysis found that using circulating microRNAs had high sensitivity and specificity in the early diagnosis of multiple myeloma.
Conference Coverage
Home care for bortezomib safe and reduces hospital visits in myeloma patients